Literature DB >> 10628403

Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.

C Becker1, I Wigheden, H Lilja.   

Abstract

Prostate-specific antigen (PSA) is the most widely used marker of prostate cancer. Assays for PSA are based on anti-PSA antibodies, and the characterization and selection of these antibodies is important for determining their optimum performance. In our study, we characterized the reactivity of 53 antibodies, submitted to the ISOBM TD-3 PSA Workshop, using free PSA, PSA complexed to alpha1-antichymotrypsin (ACT) and purified ACT. Immunoblotting was performed after native agarose gel or reducing sodium dodecyl polyacrylamide gel electrophoresis. Immunoblotting after agarose gel electrophoresis revealed 10 antibodies that recognized only the free form of PSA, and 43 antibodies that detected both free PSA and PSA-ACT. Immunoblotting of reducing sodium dodecyl-polyacrylamide gels showed the linear or conformation-dependent nature of the epitopes. Two antibodies specific for free PSA and 18 antibodies that recognized both free PSA and PSA-ACT complex recognized linear epitopes. Moreover, 7 antibodies also detected fragmented forms of PSA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628403     DOI: 10.1159/000056524

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  1 in total

1.  Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.

Authors:  Esther Llop; Montserrat Ferrer-Batallé; Sílvia Barrabés; Pedro Enrique Guerrero; Manel Ramírez; Radka Saldova; Pauline M Rudd; Rosa N Aleixandre; Josep Comet; Rafael de Llorens; Rosa Peracaula
Journal:  Theranostics       Date:  2016-05-24       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.